The transplantation of neural stem cells (NSCs) is a challenging therapeutic strategy for the treatment of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). To provide insight into the potential of the intravenous delivery of NSCs, we evaluated the delivery of NSCs marked with green fluorescent protein to the central nervous system (CNS) via intravenous tail vein injections in an ALS model. The injected cell fates were followed 1, 3, and 7 days after transplantation. The highest efficiency of cell delivery to the CNS was found in symptomatic ALS (up to 13%), moderate in presymptomatic ALS (up to 6%), and the lowest in wild-type animals (up to 0.3%). NSCs injected into ALS animals preferentially colonized the motor cortex, hippocampus, and spinal cord, and their differentiation was characterized by a decrease of nestin expression and the appearance of MAP2-, GFAP-, O4-, and CD68-positive cells. Tumor necrosis factor (TNF) administration increased the CNS delivery of transplanted cells in wild-type and presymptomatic, but not ALS symptomatic animals. Moreover, a TNF-related increase in NSC differentiation and survival was detected. Apoptosis was detected as the main cause of the loss of transplanted cells and it was influenced by TNF. Although 3 days after TNF treatment cell death was accelerated, TNF slowed down apoptosis after 7 days. This study provides elementary facts about the process occurring after NSCs leave the blood stream and enter the nervous tissue affected by inflammation/degeneration, which should help facilitate the planning of future bench-to-bedside translational projects.
INTRODUCTION
dismutase (SOD1) gene (32) . The complex pathology at the level of motor neurons includes the accumulation of neurofilaments in the perikaryon and axon, impaired Neural stem cell (NSC) transplantation provides new prospects for the treatment of neurodegenerative disaxonal transport, oxidative stress, and dysfunction of mitochondria. "The bad neighborhood" concept has reeases. However, compared with hematology, for which the use of mesenchymal stem cells is grounded in convealed astrocytes as cells responsible for producing a toxic environment for motor neurons [pathology of ALS vincing experience, the fates and beneficial potential of intravenously delivered NSCs to an organism affected reviewed by (5, 18, 19) , which has been confirmed in the opposite direction as well, because the injection of wildby a chronic neurodegenerative disease, such as amyotrophic lateral sclerosis (ALS), has only started to be type (wt) astrocytes increases the survival of motor neurons in ALS (23) . Moreover, several proinflammatory investigated (24) .
ALS is a fatal and still incurable neurodegenerative molecules, including tumor necrosis factor (TNF), are substantially increased in the advanced stage of the disdisease characterized by the loss of both upper and lower motor neurons, leading to paralysis and death, ease (6, 17) . The recent discovery of mutation within genes TDP-43 and FUS/TLS suggested impaired RNA which occurs on average 3-4 years after the onset of the first symptoms. Its highly predominant form is sporadic, processing as the common starting mechanism leading to neurodegeneration (18) . Therefore, recent advances in with only 10% of the cases classified as genetically linked familial ALS (fALS), which in 20% of the paunderstanding ALS pathology currently drive researchers to look for new therapeutic strategies aiming to retients is caused by mutations in the Cu/Zn superoxide store impaired tissue homeostasis, by the substitution of two groups, so they matched the presymptomatic and symptomatic animals in age. The number of male and lost cells and/or secretion of factors beneficial for the host tissue.
female animals in all compared groups was carefully balanced. All lines were bred and housed in our animal Until now, research on transplantation therapy in ALS has focused on the injection of cells into localized facility (ULB, Campus Erasme) according to the institutional guidelines (Animal welfare guidelines of the Uniregions of the spinal cord (23, 36) . However, intravenously injected NSCs seem to yield promising effects in versite Libre de Bruxelles), and all experiments were performed according to the ethical regulations (Animal central nervous system (CNS) affected by stroke (20) , Huntington disease (21), multiple sclerosis (30), and welfare guidelines of the Universite Libre de Bruxelles) (http://www.ulb.ac.be/facs/medecine/ compression spinal cord injury (33) . In other studies, therapeutic efficiency was improved using TNF, which, comiteethiqueanimal.html). Transgenic rats were genotyped by PCR using specific primers for the human as in the case of mesenchymal cells-based therapy of infarcted myocardium, increased the permeability of the SOD1 transgene as described (29) . To obtain GFP expressing NSC, SD-eGFP rats were mated and embryos blood vessel wall and cell engraftment (14).
The main aim of this study was to use the blood dewere isolated on day 16 of pregnancy under deep anesthesia using 30% ketamine (Ketalar, Pfizer) and 20% livery route to explore the fates of engrafted NSCs in the CNS affected by the neurodegenerative process.
xylazine (Rompun, Bayer) in PBS (1 ml/500 g of body mass). After obtaining the embryos, animals were euMoreover, the potential of TNF in increasing cell delivery efficiency and its possible influence on NSC behavthanized by decapitation. NSCs were injected into the rats' tail vein. Before ior in the ALS environment were analyzed. After injection of 10 7 green fluorescent protein (GFP)-marked injection, rats were anesthetized using the same procedure mentioned above (ketamine/xylazine). To decrease NSCs, their migration to the preferential sites-the brain cortex, hippocampus, and spinal cord-was dethe blocking of pulmonary veins by NSCs and reduce subsequent cell loss, before treatment with NSCs all anitected. Unlike in wt animals, where grafting efficiency was very low, injected NSC colonized the CNS of ALSmals received 25 ng of the potent pulmonary vein dilatation drug sodium nitroprusside (Merck, M-6541). It was affected animals, and the process was more efficient in symptomatic than in presymptomatic animals. Successdiluted in 100 µl of physiological solution (0.9% NaCl) and injected in the tail vein 5 min before NSC delivery. fully engrafted cells started to differentiate, and the process showed a tendency to be faster in ALS-affected ani-
In order to open the blood-brain barrier (BBB), half of the animals (N = 27) received 150 ng of TNF (Pepromals. Treatment with TNF increased cell delivery in presymptomatic and wt animals as well as cell survival tech, 400-14) diluted in 100 µl of physiological solution into the tail vein 3 h before NSC injection (8). Immediand differentiation in all tested groups. The unexpected failure of TNF to increase cell delivery in ALS sympately before injection, cells were harvested from tissue flasks by centrifugation, dissociated using the described tomatic animals suggests a role of this molecule in attracting NSCs to the CNS affected by ALS.
trypsine procedure (see Neural Stem Cells section), twice washed with fresh stem cell medium, and dis-MATERIALS AND METHODS solved in a volume of 1 ml. Finally, animals received Experimental Animals 10 7 of cells in 1 ml of physiological solution with 0.2% glucose, using a Dual Syringe Pump injector (Harvard For the purpose of this study three rat strains were used: 1) SOD1G93A rat model for ALS, characterized Apparatus, MA1 70-2209). The speed of the injection was 100 µl/min. To obtain tissue for histological analyby the presence of multiple copies of the mutated human SOD1 gene (SOD1G93A) on the Sprague-Dawley backses, animals were transcardially perfused with 4% paraformaldehyde (Merck). The procedure led to euthanasia. The embryonic brain cortex was staged (34) and isolated using scissors for micromanipulation (Fine Science Bal/2Rrr]}, and 3) wild-type Sprague-Dawley line. The starting pool of three groups of animals (presymptomTools), and the tissue was kept in HBSS (Gibco). Dissociation of the tissue and obtaining of the cells was peratic, symptomatic, and wt) were divided in two additional groups: those treated by TNF and those not TNF formed using trypsine solution (0.05% Try-Edta, Gibco). Tissue was incubated for 10 min at 37°C, after which treated. This made a total of six groups with nine animals in each (Table 1) . Presymptomatic ALS rats were reaction was stopped using 2 ml of NSC medium (DMEM/F12, Gibco; N2 and B27, Invitrogen; penicilin/ on average 14 weeks, whereas symptomatic rats were 26 weeks old. Control wt animals were also divided into streptomicin, Gibco) with 10% fetal calf serum (Gibco) and 0.001% DNAse (Roche). The solution was centrichemistry for differentiation, proliferation, and GFP markers, this allowed direct fluorescent detection of casfuged, supernatant discarded, and cells resuspended in fresh NSC medium. Cells were cultured in NSC medium pase activity. with 2 µg/ml of EGF and 1 µg/ml of FGF2 (both PeproCell Counting tech) in Sarstedt tissue culture flasks. For the purpose For the purpose of this study, we analyzed the numof transplantation to experimental animals, a sufficient ber of transplanted cells in the whole brain and the spinumber of cells had been obtained by 2-3 weeks of nal cord. Cell counting was performed on 10-µm-thick expansion in the described medium. Cells were passaged paraffin sections, and cell numbers were expressed eionce in a week by plating 2 million cells per one T75
ther as an absolute cell number (the brain cortex) or as flask. In parallel to transplantation, a small sample from average densities (all analyzed tissues). The absolute the injected pool (10 5 cells) was transferred to a 96-well cell number in the brain cortex was assessed by counting plate (Sarstedt) and tested for a nestin marker. In this GFP-positive cells in the cortex in every 20th section. way, it was ensured that experimental animals had been An estimation of the total number of cells was then obtreated by undifferentiated multipotent NSCs. tained using the following calculation: because the averImmunohistochemistry age diameter of half of the rat brain was 5 mm, this led to an average of 25 sections in an average distance of For the purpose of this study the following primary every 200 µm. Paraffin sections (10 µm thick) of analyzed tissue One day after intravenous injection of 10 7 GFPmarked NSCs, they were detected in the CNS of all aniwere deparaffinized and washed/permeabilized using wash buffer (1 × PBS + 0.5% Triton-X 100). Blocking mal groups, but the number of cells and cell densities were significantly different (p ≤ 0.05) ( Table 1 ). The was carried out for 2 h using a blocking solution (wash buffer plus 5% goat serum and 0.5% BSA). Primary anthree major sites of cell invasion in ALS rats were the brain cortex, dentate gyrus of hippocampus, and spinal tibodies were incubated overnight at 4°C at the appropriate dilution in blocking solution. Excess primary anticord (Table 1 , Fig. 1 ). In wt animals, the highest density of cells was found in the hippocampus. The maximum body was washed for 5 min (three times) and then 15 min (three times) and secondary antibodies were incuefficiency of cell delivery in the CNS, reaching up to 13% was found in ALS symptomatic animals: 9 × 10 5 in bated for 2 h at room temperature before another round of washing. For the majority of slides, DAPI was used the brain cortex, 2.5 × 10 5 in the spinal cord, 10 5 in the other parts of the brain, and 5 × 10 4 in the hippocampus. as a nuclear counterstain. Slides were mounted and images were taken using a Zeiss Axiovert 200M fluoresIn presymptomatic animals, the average number was 50% lower, so grafting efficiency reached 6%. The difcent microscope.
ference in efficiency rates of cell delivery between preDetection of Apoptosis symptomatic and symptomatic ALS animals was because of the differences in migration to the cortex. Average Apoptosis was analyzed in two rats from every group using the Flivo Apoptosis Kit (Immunochemistry Technumbers of cells found in the hippocampus, spinal cord, and the rest of the brain were not significantly different nologies, #982). According to the manufacturer's protocol, 100 µl of freshly prepared solution was injected into between presymptomatic and symptomatic ALS animals. A rather low rate of CNS invasion was revealed in wt the rat's tail vein. The rat was sacrificed after 1 h and 10-µm-thick paraffin sections were obtained using a animals, reaching 0.3% (Table 1, Fig. 2 ).
To increase the efficiency of cell delivery and test the standard procedure. Apart from routine immunohisto- ) 3 1 ± 2 2 6 ± 3 1 6 ± 3 2 0 ± 2 1 ± 1 7 ± 3 Average cell density in the dentate gyrus of hippocampus (mm   2   ) 194 ± 19* 183 ± 12 191 ± 12* 197 ± 6 6 ± 2 3 6 ± 2 † Average cell density in the spinal cord (mm 2 )
7 ± 2 § 7 ± 1 8 ± 2 § 9 ± 1 1 ± 0.6 3 ± 1 Average cell density in the rest of the brain (mm 2 ) 1± 0.4 The efficiency of cell delivery and change in cell number in the brain cortex in presymptomatic and symptomatic ALS rats, and their wt counterparts 1, 3, and 7 days after intravenous delivery. The highest efficiency of delivery was observed in symptomatic, moderate in presymptomatic animals, and very low in wt animals. TNF increased cell invasion efficiency in wt and presymptomatic, but not in symptomatic animals. Three days after injection, cell loss was observed in all tested groups, and it was accelerated in TNF-treated animals. Although 7 days after injection the number of cells continued to decrease, the loss was decelerated in TNF-treated animals. Statistical analyses were made using the ANOVA test. On day 1, a significant difference was observed when wt was compared to TNF-treated wt group (p < 0.0001) and for presymptomatic ALS compared to presymptomatic ALS-TNF treated group (p < 0.01). On day 3, a significant difference was observed between the symptomatic and symptomatic/TNF-treated group (p < 0.05). On day 7, both presymptomatic and symptomatic groups compared to their TNF-treated counterparts revealed significant differences in the number of cells (p < 0.05). Therefore, the observed differences between tested groups as observed by ANOVA were significant (F = 451.57, p < 0.0001). The change in the number of cells during time in each tested group was significant (p < 0.0001), except for all three tested points in wt group and the difference between day 3 and 7 for the TNF-treated wt group. Therefore, the observed changes in the number of cells for each tested group over time as determined by ANOVA were significant (F = 319.19, p < 0.0001).
role of TNF in attracting NSCs to the CNS affected by
The Role of Apoptosis in Gradual Cell Loss of Grafted NSCs ALS, 150 ng of TNF was injected into the blood stream 3 h before NSC injection. TNF had a dramatic positive effect when administered to the wt animals (Table 1, To analyze the survival of grafted cells, we compared their total numbers 1, 3, and 7 days after cell injection Fig. 2) . The cell densities significantly increased in the brain cortex (up 650%, p ≤ 0.05), and the hippocampus (Table 1, Fig. 2 ). In addition, to enhance cell grafting, half the animals were treated by TNF. Programmed cell (up 500%, p ≤ 0.01), whereas in the spinal cord and the other parts of the brain the increase was not significant. death was analyzed using caspase assay (Flivo) (Fig. 3) . One day after injection of NSCs, the number of enThus, the efficiency of cell injection in wt animals increased six times (reaching 2%). Administering TNF grafted cells dying by apoptosis in the brain cortex, hippocampus, and spinal cord was similar in all untreated significantly increased (27%) cell invasion in presymptomatic ALS animals and had no significant negative groups and was around 4%. TNF administration increased apoptotic cell death of transplanted cells, which effect on ALS symptomatic animals ( Table 1, Fig. 2 ). reached 7%, and was observed in both wt and presympwhereas the ratio of cell death found within the hippocampus was rather low (1%) and constant. tomatic ALS animals. TNF did not influence the rate of cell death in symptomatic ALS animals.
Differentiation of NSCs Delivered to the CNS Three days after injection, the total number of cells
by Blood Stream Route significantly decreased in all six analyzed groups of animals. In presymptomatic and wt animals, cell loss was
To gain an insight into the differentiation of injected cells, the following markers were used: nestin for undifsignificantly larger when treated by TNF (Fig. 2) . Surprisingly, caspase assay revealed a significantly higher ferentiated NSC, MAP2 for neurons, GFAP for astrocytes, O4 for oligodendrocytes, and CD68 for microglia ratio of cells expressing the apoptotic marker in untreated (17%) than TNF-treated animals (12%). More- (Fig. 4) . Results are visualized in Figure 5 . Before injection (day 0), all NSCs were uniformly expressing nestin over, the coexpression of caspase activity and nestin was not found, suggesting a correlation between the onset of and no other differentiation markers. One day after injection, the majority (more than 85%) of injected cells differentiation and programmed cell death.
Although 7 days after injection, the numbers of cells continued to express nestin. The rest of the cells started to express other differentiation markers. The simplest continued to decrease in all analyzed groups, TNFtreated animals significantly slowed their rate of cell pattern was found in untreated wt animals, where 10% of cells started to express MAP2, and in half of them loss (Fig. 2) . The most pronounced effect was observed in symptomatic TNF-treated animals that, after 7 days, coexpression with nestin was also found. The main difference between ALS and wt animals after 1 day was had more detectable injected cells than their untreated counterparts. Slowing of the decrease in cell number that in ALS animals, besides early observed neuronal fate, GFAP-and O4-positive cells were already present. was observed in TNF-treated presymptomatic and wt animals as well. Moreover, TNF-treated animals exhibited None of the tested groups showed an expression of CD68 1 day after injection. a lower ratio of programmed cell death, thereby continuing the trend observed at 3 days after injection. Changes Three days after injection, levels of nestin substantially decreased in all analyzed groups of animals. The in the cell death ratio in the spinal cord and the rest of the brain were the same as those observed in the cortex, majority of cells started to express either MAP2 or GFAP, while the expression of O4 was rather low and contributed to neurogenesis, the expression of Ki67 was tested. The majority of GFP-injected cells in all tested uniform. CD68-positive cells were also found. Similar to 1 day after injection, 3 days after injection the ALSanimals expressed Ki67, but only 1 day after injection. In the later tested stages (3 and 7 days), some level of affected animals and wt animals treated by TNF showed a tendency towards a larger ratio of differentiated cells, mitotic activity was found in the hippocampus. Moreover, signs of tumorigenicity were not observed in any concomitant with a lower ratio of nestin expression. Thus, 3 days after injection more MAP2-, GFAP-, and part of the CNS.
CD68-positive cells were found in ALS-affected and
Presence of Grafted NSCs in the Spleen, Liver, TNF-treated wt animals than in wt animals (Fig. 4) . StaLungs, and Kidney tistically significant differences (p ≤ 0.05) were observed when the wt and ALS animals were compared Cells injected into the blood stream invaded different tissues. The majority were found 1 day after injection in for levels of GFAP at days 1 and 3, and for MAP2 at day 1. the spleen (3 × 10 6 ), liver (2 × 10 6 ), lungs (3 × 10 5 ), and kidney (4 × 10 4 ) (Fig. 6 ). There were no signs of neuSeven days after injection, in all analyzed groups, a decrease in the MAP2 ratio and increase in the GFAP ronal or glial differentiation or caspase-mediated cell death 1 day after injection. However, 3 days after injecratio was found (Fig. 4) . Although in wt animals the proportion of the astrocytic population was kept low, tion, the number of cells substantially decreased and the majority were dying by apoptosis. Seven days after inin all other groups the dominance of GFAP prevalence become substantial. The number of CD68 cells remained jection, only several remaining cells dying by apoptosis were found. close to the levels observed at 3 days and its levels in wt rats was lower than both ALS-and TNF-treated DISCUSSION groups of wt animals. The expression of nestin in the brain cortex and spinal cord almost completely disapCell transplantation using the blood stream represents a promising approach in the therapy of neurodegenerapeared. However, in all groups of analyzed animals the levels of nestin in the dental gyrus of hippocampus retive diseases (13, 25) . The main goal of this work was to analyze the fates of NSCs after they leave the blood mained at the same level as 3 days after injection.
To (38) and survival. We focused on the quantity of cell colonization, cell differentiation, and cell death, which enabled suggested that a disrupted BBB was a possible independent factor in ALS pathology, which was recently demus to provide the elementary facts about the behavior of NSCs in the ALS-affected and wt CNS. In other similar onstrated in an ALS rat model (26) . However, one should be careful when correlating leakage of solutes studies, cell fates and animal survival rates were obtained using human umbilical cord blood cells (10), or (e.g., Evans blue), which suggest a disrupted BBB and cell invasion into the neuropil. It is indeed probable that NSCs in the mouse model of experimental encephalomyelitis (30). In those studies, cell engraftment and im-(neural stem) cells migrate thorough the basement membrane of postcapillary venules using the same mechaprovement in animal condition was reported.
One of the main results of this study was that the nism as leukocytes do [reviewed in (2)]. In vitro endothelial systems revealed that NSCs specifically interact blood stream injection efficiency of cell grafting was much higher in ALS than wt animals. This result is comwith the endothelium and migrate into the subendothelial space where their differentiation is supported (7). parable to the report of Pluchino (30), who declared that no injected cells were found in the wt brain when the To test the influence of TNF on NSC engraftment and its role in attracting NSCs in ALS-affected animals blood stream route was used (we report an efficiency of 0.3%), and showed that in an experimental autoimmune and their wt counterparts, half the animals were treated by this molecule. The rationale for that was reported encephalitis model, NSCs have the ability to cross the BBB and populate the CNS with cell densities compara-TNF-caused increased endothelial permeability via a tissue factor-dependent mechanism during which the cyble to ours (10-30 cells/mm 2 ). The first indication that the BBB might be affected in ALS came from Leonardi toskeleton rearranges (8). In addition, it has been shown that TNF increased both the adhesiveness and migration of TNF on long-term regeneration has been suggested: compressive brain injury in TNF KO mouse caused proof polymorphonuclear leukocytes (35) and mesenchymal stem cells (14). Here, we have shown that TNF influlonged motor deficits when compared with wt animals (27) , and levels of TNF increased during the late phase ences NSC delivery, survival, and differentiation. In wt and presymptomatic ALS animals, TNF facilitated the of sciatic nerve regeneration (4). Although Grassi et al.
(11), in in vitro conditions, reported that TNF increased invasion of NSCs within the brain tissue, which was not apparent in symptomatic ALS animals, probably besynaptic activity and synaptogenesis, which is one of the prerequisites in the survival of NSC-derived neurons, we cause of an already high level of TNF in the symptomatic stage of the disease (6). This suggests an important did not detect an increase in the ratio of synaptic markers in TNF-treated animals. role of this molecule in attracting NSCs to the CNS affected by ALS. A surprising result was obtained when
Our work also showed that injected cells do not distribute equally in the CNS of ALS animals. This can be cell survival was analyzed. Although during the first day after injection cell death in TNF-treated animals was inexplained by the fact that for successful engraftment and survival, chemoattractive cytokines, and/or a supportive creased, the rate of cell death after 3 and 7 days slowed down, which resulted in increased cell survival in TNFneurogenic niche (hippocampus) is required. The molecular mechanism of NSC attraction by cytokines, includtreated animals. One possible explanation for this effect is that TNF can act through the p75 receptor, promoting ing TNF, were elucidated (3,28), and it was reported that hematopoetic stem cell transplantation resulted in cell survival [reviewed by Kraft et al. (16) ]. Moreover, cell death exclusively affected cells that were starting to an accumulation of cells exclusively in the sites affected by neurodegeneration (1) . Therefore, NSCs probably do express differentiation markers. This is in congruency with the finding that undifferentiated NSCs do not exinvade regions of the CNS following chemoattractive signals, and the disrupted BBB in ALS possibly acts as press caspase 8, which is crucial for initiating the extrinsic death pathway (31). The possible beneficial effect an additional precipitating factor of this process. 
